Literature DB >> 25616916

Complete response of acquired FV inhibitor to rituximab.

Edmond S K Ma1, Raymond H S Liang, Kent-Man Chu, George K K Lau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25616916     DOI： 10.1007/s12185-015-1742-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

Review 1.  Acquired factor V inhibitors.

Authors:  P Knöbl; K Lechner
Journal:  Baillieres Clin Haematol       Date:  1998-06

Review 2.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

3.  Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis.

Authors:  Eric Chun-Yet Lian; Andreas G Tzakis; David Andrews
Journal:  Am J Hematol       Date:  2004-12       Impact factor: 10.047

4.  Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays.

Authors:  Maria T Grosse Perdekamp; David A Rubenstein; Jolyon Jesty; Mae B Hultin
Journal:  Blood Coagul Fibrinolysis       Date:  2006-10       Impact factor: 1.276

Review 5.  Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.

Authors:  Michael B Streiff; Paul M Ness
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157

Review 6.  Acquired factor V inhibitor. A problem-based systematic review.

Authors:  Ai Leen Ang; Ponnudurai Kuperan; Chin Hin Ng; Heng Joo Ng
Journal:  Thromb Haemost       Date:  2009-05       Impact factor: 5.249

7.  Successful treatment with rituximab in a patient with an acquired factor V inhibitor.

Authors:  Agnes Lebrun; Catherine Leroy-Matheron; Jean-Benoit Arlet; Pablo Bartolucci; Marc Michel
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047
  7 in total
  1 in total

1.  A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.

Authors:  Yasuko Kadohira; Shinya Yamada; Tomoe Hayashi; Eriko Morishita; Hidesaku Asakura; Akitada Ichinose
Journal:  Int J Hematol       Date:  2018-04-02       Impact factor: 2.319
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.